Grade My Investments
HomeFree Stock Grades › HIMS

Hims & Hers Health, Inc. (HIMS) Stock Grade

HIMS · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$7.3B
P/E Ratio
56.9
Revenue Growth (YoY)
+59.0%
Net Margin
5.5%
Return on Equity
23.7%
Dividend Yield
None

About Hims & Hers Health, Inc.'s fundamentals

Hims & Hers is a $7.3 billion telehealth company growing revenue at a 59% year-over-year rate, demonstrating strong demand for its services. The company maintains a net profit margin of 5.5% while generating a 23.7% return on equity, indicating reasonable efficiency in converting sales to earnings and deploying shareholder capital effectively. However, the stock trades at a P/E ratio of 56.9, which is elevated and reflects significant growth expectations already priced into the valuation. The company does not currently pay a dividend.

Track HIMS free — no credit card required. Live grade + monthly AI report →